Alfan Pharmaceuticals connects world-class pharmaceutical supply with Southeast Asian healthcare demands. From API sourcing to finished formulations, regulatory affairs to MA holdings — we are your integrated partner across the pharmaceutical value chain.
Founded in 2022, Alfan Pharmaceuticals is a dynamic and growing pharmaceutical enterprise with a clear focus on ASEAN markets. We have established operating companies in both Hong Kong and the Philippines, with the Philippine market serving as our key strategic hub.
Our business spans medical packaging materials, Active Pharmaceutical Ingredients (API), finished formulations, and medical devices — providing comprehensive, high-quality pharmaceutical solutions to the market.
Through in-depth cooperative relationships with leading pharmaceutical enterprises in China and ASEAN, we leverage world-class R&D, production, and supply chain capabilities to bring reliable, high-performance products to the region.
From regulatory strategy to distribution, we provide end-to-end pharmaceutical services tailored for ASEAN market entry and expansion.
Full regulatory lifecycle management — product registration, dossier preparation, regulatory strategy, and compliance across ASEAN jurisdictions, with deep expertise in Philippines FDA requirements.
Marketing Authorization holding services providing a local legal presence for foreign manufacturers. We manage renewals, variations, and pharmacovigilance obligations as your in-market representative.
Licensed pharmaceutical import and distribution channels across the Philippines and ASEAN. Temperature-controlled logistics, customs clearance, and last-mile delivery to healthcare providers.
In-licensing and out-licensing of pharmaceutical products, connecting Chinese manufacturers with ASEAN market opportunities and ASEAN innovators with regional distribution networks.
API sourcing, finished formulation procurement, and medical packaging supply — backed by qualified supplier networks across China and ASEAN, with quality assurance at every step.
ASEAN pharmaceutical market intelligence, competitive landscape analysis, pricing strategy, and go-to-market planning for companies entering or expanding within Southeast Asian healthcare markets.
A diversified portfolio spanning the pharmaceutical value chain, reducing single-category exposure while enabling integrated solutions for partners.
Sourced from GMP-certified manufacturers across China and ASEAN. Quality-driven supplier qualification with competitive pricing for both established molecules and niche generics.
Oral solids, injectables, topicals, and sterile dosage forms. Partner manufacturing facilities hold EU-GMP, US-FDA, and PIC/S certifications for multi-market registration.
Primary and secondary packaging materials compliant with pharmacopeia standards. Blister films, aluminum foil, glass vials, rubber stoppers, and specialty containers.
Class I to Class III medical devices, including consumables, diagnostic equipment, and specialized instruments. ASEAN medical device registration and distribution support included.
Hong Kong for corporate and financial operations. Philippines for regional market execution — creating a powerful ASEAN-facing platform.
Whether you're a manufacturer seeking ASEAN market access or a buyer sourcing pharmaceutical products — we're ready to collaborate.